Literature DB >> 25323241

Analysis of advanced lung cancer patients diagnosed following emergency admission.

Daichi Fujimoto1, Ryoko Shimizu1, Takeshi Morimoto2, Ryoji Kato1, Yuki Sato1, Mariko Kogo1, Jiro Ito1, Shunsuke Teraoka1, Takehiro Otoshi1, Kazuma Nagata1, Atsushi Nakagawa1, Kojiro Otsuka1, Nobuyuki Katakami1, Keisuke Tomii1.   

Abstract

Data on prognosis and predictors of overall survival in advanced lung cancer patients diagnosed following emergency admission (DFEA) are currently lacking. We retrospectively analysed data from 771 patients with advanced nonsmall cell lung cancer between April 2004 and April 2012. Of the 771 patients, 103 (13%) were DFEA. DFEA was not an independent predictor of overall survival by multivariate Cox proportional hazard models, whereas good performance status (PS), epidermal growth factor receptor gene mutation, stage IIIB, adenocarcinoma and chemotherapy were independent predictors of overall survival (hazard ratio (95% CI) 0.36 (0.29-0.44), p<0.001; 0.49 (0.38-0.63), p<0.001; 0.64 (0.51-0.80), p<0.001; 0.81 (0.67-0.99), p=0.044; and 0.40 (0.31-0.52), p<0.001, respectively). Good PS just prior to opting for chemotherapy, but not at emergency admission, was a good independent predictor of overall survival in DFEA patients (hazard ratio (95% CI) 0.26 (0.12-0.55); p<0.001). DFEA is relatively common. DFEA and PS at emergency admission were not independent predictors of overall survival, but good PS just prior to opting for chemotherapy was an independent predictor of longer overall survival. Efforts to improve patient PS after admission should be considered vital in such circumstances.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2014        PMID: 25323241     DOI: 10.1183/09031936.00068114

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  3 in total

1.  Rapid response in a critical lung adenocarcinoma presenting as large airway stenoses after receiving stent implantation and sequential rebiopsy guided ALK inhibitor therapy: a case report.

Authors:  Ling Ding; Cheng Chen; Yuan-Yuan Zeng; Jian-Jie Zhu; Jian-An Huang; Ye-Han Zhu
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Authors:  Daichi Fujimoto; Ryoji Kato; Takeshi Morimoto; Ryoko Shimizu; Yuki Sato; Mariko Kogo; Jiro Ito; Shunsuke Teraoka; Kazuma Nagata; Atsushi Nakagawa; Kojiro Otsuka; Keisuke Tomii
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

3.  Higher frequency of new chest tumor diagnoses in emergency department due to the COVID-19 pandemic.

Authors:  Klaudia Krzyzaniak; Mariusz Sieminski
Journal:  Am J Emerg Med       Date:  2022-02-20       Impact factor: 4.093

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.